UBC Medicine entrepreneurs join HATCH Builder to advance innovative health solutions - UBC Faculty of Medicine

New BrunswickThe federal government has selected Ontario-based construction giant EllisDon Corp. to design and build a health centre for prison inmates in southeast New Brunswick. Federal government selected EllisDon Corp. to design, build facility by 2032Shane Magee · CBC News · Posted: Sep 29, 2026 6:10 PM EDT | Last Updated: September 29Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Dominic LeBlanc, Liberal Beauséjour MP and federal trade minister, speaking at a news conference inside Dorchester Penitentiary on Tuesday. (Shane Magee/CBC)The federal government has selected Ontario-based construction giant EllisDon Corp. to design and build a health centre for prison inmates in southeast New Brunswick. The 155-bed facility will be constructed on the grounds of Dorchester Penitentiary, replacing the 53-bed Shepody Healing Centre inside the prison. The centre will offer mental and physical health care in French and English to men and women in the federal correctional system.

Matt Nelson is an automotive journalist with nearly a decade of experience in all things cars.  He's spent years working at dealerships in sales, finance, and service. He's since traded in his pens and wrenches for a keyboard, and leveraged the expertise gained from his work experience into a writing career. When it comes to cars, facts, and the truth, Matt’s equal love for all three meant automotive journalism was the only path forward. Ever since the age of six, when he’d spend his time helping his father fix his family’s old Buick, Matt has had a keen interest in anything and everything with four wheels. Naturally, once Matt started working, he ensconced himself in the automotive industry and held positions spanning from car detailer, mechanic, to automotive sales and finance. Because he’s seen it all, driven most, and heard a lot, auto journalism came naturally to him. With a passion for cars like Matt’s, it’s safe to say every article will showcase his penchant for truth, accuracy, and overarching desire to make sense of the modern, complex automotive world. This means every one of his readers can be at the forefront of the most important automotive news.

A common liver disease affecting nearly 30% of adults worldwide is far more complex than previously understood. Researchers at Mayo Clinic have identified five biologically distinct forms of the condition, each associated with different risks of serious health complications, including heart disease, liver failure, cancer, and the need for a liver transplant. The findings, published in Nature Communications, come from a collaboration between Mayo Clinic and Virginia Tech. Scientists discovered that metabolic dysfunction-associated steatotic liver disease, or MASLD, can develop through several different biological pathways. Some are closely connected to obesity and diabetes, while others appear to be driven by inherited genetic differences.

IntroductionHypertension is a major global health concern and a leading cause of morbidity and mortality [1]. It is estimated that more than 19 million annual deaths are attributed to cardiovascular disease (CVD) worldwide [2]. In Japan, high blood pressure (BP) has been consistently identified as a strong risk factor for the national burden of CVD, in terms of notable incidence, mortality, direct/indirect healthcare costs, and quality-adjusted life years (QALYs) associated with this condition [3, 4]. Although age-specific mean BP declined in Japan over recent decades [5], hypertension remains a critical public health issue, particularly because of the rapid aging population. The proportion of individuals aged ≥65 years is projected to reach approximately 35% by 2040 in Japan [6], highlighting a potentially higher future burden of hypertension in this country. While the prevalence of hypertension increases with age, population aging may offset the benefits of declining BP levels in each age group. As a result, the future burden of hypertension in Japan remains uncertain.

It also established a $2.5m professorship to support its cardiothoracic surgery leadership. The National Heart Centre Singapore (NHCS) has launched a centre to develop cardiovascular disease models using heart cells derived from Asian patients. The Centre for Integrative Human Cell Research and Translation (CIPHER), launched on 16 October, uses blood samples from Asian patients to grow heart muscle cells for disease research and drug testing. It is the first centre in Singapore dedicated to cardiovascular research using this approach. NHCS also announced the establishment of the Tong Ming Chuan Professorship in Cardiothoracic Surgery, the first professorship in the field under the SingHealth Duke-NUS Academic Medical Centre (AMC). CIPHER aims to address gaps in cardiovascular research, as some heart conditions develop earlier and present differently in Asian populations than in Western populations. Many treatments have historically been developed using models that do not fully reflect Asian biology. The centre uses blood samples to generate induced pluripotent stem cells, which are developed into heart muscle cells carrying features of each patient’s disease.